Inotiv (STU:BS50) EV-to-Revenue : 0.86 (As of May. 11, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inotiv EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Inotiv's enterprise value is €467.1 Mil. Inotiv's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €542.9 Mil. Therefore, Inotiv's EV-to-Revenue for today is 0.86.

The historical rank and industry rank for Inotiv's EV-to-Revenue or its related term are showing as below:

STU:BS50' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.53 Med: 0.95 Max: 11.13
Current: 0.86

During the past 13 years, the highest EV-to-Revenue of Inotiv was 11.13. The lowest was 0.53. And the median was 0.95.

STU:BS50's EV-to-Revenue is ranked better than
84.89% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.24 vs STU:BS50: 0.86

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Inotiv's stock price is €3.82. Inotiv's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €21.09. Therefore, Inotiv's PS Ratio for today is 0.18.

Inotiv EV-to-Revenue Historical Data

The historical data trend for Inotiv's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv EV-to-Revenue Chart

Inotiv Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EV-to-Revenue

Get a 7-Day Free Trial

1.23

1.45

5.59

1.46

0.81

Inotiv Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.87	0.84	0.89	0.81	0.86

Competitive Comparison of Inotiv's EV-to-Revenue

For the Diagnostics & Research subindustry, Inotiv's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inotiv's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Inotiv's EV-to-Revenue falls into.

Inotiv EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Inotiv's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	467.062	/	542.936
	=	0.86

Inotiv's current Enterprise Value is €467.1 Mil.
Inotiv's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €542.9 Mil.

Inotiv (STU:BS50) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Inotiv's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3.82	/	21.089
	=	0.18

Inotiv's share price for today is €3.82.
Inotiv's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.09.

Inotiv EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Inotiv's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Inotiv (STU:BS50) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (STU:BS50) » Definitions » EV-to-Revenue

Comparable Companies

STIM FONR BNR ACRS PRPH VNRX MDXH BDSX BIOQ PSNL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NOTV:USA

Address

2701 Kent Avenue, West Lafayette, IN, USA, 47906

Website

https://www.inotivco.com

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv (STU:BS50) Headlines

No Headlines